ZG16 and adenocarcinoma: In summary, this study identified a set of differentially expressed genes in CRC, including FcGBP, CLCA1, ADH1C, COL1A1, ZG16, which could be strong candidates to be used as biomarkers of colorectal adenoma-adenocarcinoma progression.